Clinical trials: Chronic Gastritis
Chronic Atrophic Gastritis, Hypergastrinaemia
YF476 and Type I Gastric Carcinoids
The aim of the study is to find out if the experimental medicine, YF476, can make gastric carcinoids, a rare type of stomach tumour, shrink and disappear.
- Conditions
- Chronic Atrophic Gastritis, Hypergastrinaemia, Type I Gastric Carcinoids
- Trial name
- NCT01339169
- Testing
- YF476
- Where
- United Kingdom
- Volunteers
- 8 people
- Sponsor
- Trio Medicines Ltd.
Acute Gastritis, Chronic Gastritis
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
The purpose of study is to confirm the efficacy of DWP14012 X mg QD, DWP14012 Y mg BID compared to placebo in patients with Acute or Chronic Gastritis
- Trial name
- NCT04341454
- Testing
- DWP14012 X mg, DWP14012 Y mg
- Where
- South Korea
- Volunteers
- 327 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Gastritis Acute, Gastritis Chronic
To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients with Gastritis
- Trial name
- NCT05163756
- Testing
- DW1903, DW1903-R1
- Where
- South Korea
- Volunteers
- 332 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Chronic Atrophic Gastritis (CAG)
To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)
The purpose of this study is to determine whether Gastropyloric Complex Capsules are safe and effective in the treatment of chronic atrophic gastritis (CAG).
- Trial name
- NCT01474044
- Testing
- Gastropylor Complex Capsules
- Where
- China
- Volunteers
- 851 people
- Sponsor
- Xinjiang Biochemical Pharmaceutical Co., Ltd.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.
This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis.
- Trial name
- NCT01817556
- Testing
- Stillen Tab., Mucosta Tab.
- Where
- South Korea
- Volunteers
- 258 people
- Sponsor
- Dong-A ST Co., Ltd.
Functional Dyspepsia
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
The study is conducted in patients with functional dyspepsia or chronic gastritis. The purpose of this study is to: assess whether the dose of Itopride Hydrochloride 150 mg extended release tablets, taken once daily has a similar…
- Trial name
- NCT06217393
- Testing
- Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets
- Where
- 19 sites in Armenia, Malaysia and 3 more
- Volunteers
- 564 people
- Sponsor
- Abbott
Gastritis Acute, Gastritis Chronic
To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients
Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis
- Trial name
- 2 (NCT03443804)
- Testing
- Test(DW1401), Reference(Stillen tab.)
- Volunteers
- 462 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Erosive Gastritis
Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis
The purpose of this study is to Assess the Efficacy and Safety of SK-MS10 in subjects With acute and chronic gastritis.
- Trial name
- NCT01578811
- Testing
- SK-MS10
- Where
- South Korea
- Volunteers
- 102 people
- Sponsor
- SK Chemicals Co., Ltd.
Chronic Atrophic Gastritis, Hypergastrinemia
YF476 and Type I Gastric Carcinoids (Norway)
The aim of the study is to find out if the experimental medicine, YF476, can make gastric carcinoids, a rare type of stomach tumour, shrink and disappear.
- Conditions
- Chronic Atrophic Gastritis, Hypergastrinemia, Type I Gastric Carcinoids
- Trial name
- NCT01444014
- Testing
- YF476
- Where
- Norway
- Volunteers
- 8 people
- Sponsor
- Trio Medicines Ltd.
Acute Gastritis, Gastric Ulcer
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
This is a self-controlled, open, multiple-center clinical trial.
- Trial name
- NCT01190657
- Testing
- Selbex
- Where
- 26 sites in China
- Volunteers
- 1,184 people
- Sponsor
- Eisai Co., Ltd.
Gastritis, Acute Gastritis
Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis
This Phase 4, multicenter, randomized, double-blind, active-controlled, non-inferiority study aims to evaluate the non-inferiority of Stoem Tab. compared to Stillen Tab.
- Conditions
- Gastritis, Acute Gastritis, Chronic Gastritis
- Trial name
- NCT07631065
- Testing
- Stillen Tab., Sto M Tab.
- Volunteers
- 470 people
- Sponsor
- Mather's Pharm. Co., Ltd.
Acute Gastritis, Chronic Gastritis
Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients
The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.
- Trial name
- NCT02356679
- Testing
- Eupasidin-s Tab, Stillen Tab.
- Where
- 10 sites in South Korea
- Volunteers
- 230 people
- Sponsor
- Chong Kun Dang Pharmaceutical
Chronic Gastritis Caused by Helicobacter Pylori
Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis
H. pylori positive patient volunteers that passed the selection criteria are recruited and divided into a test and a control group.
- Trial name
- NCT02721355
- Testing
- GastimunHP
- Where
- Vietnam
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Immunology Research Institute in Gifu
Gastritis
Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
- Trial name
- NCT06948487
- Where
- South Korea
- Volunteers
- 12,000 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Acute Gastritis, Chronic Gastritis
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
This PMS is a non-interventional, prospective, single-arm, multi-center surveillance in accordance with Korean regulation, 'Standard for Re-Examination of New Drugs'.
- Trial name
- MCTSRPMS (NCT05048069)
- Testing
- Mucosta®SR Tablets 150mg(Rebamipide)
- Where
- South Korea
- Volunteers
- 600 people
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
This is a multicenter, double-blinded, double-dummy, active-controlled, randomized, Phase III clinical trial to evaluate the efficacy and safety of DA-6034 and to demonstrate the non-inferiority of DA-6034 compared with…
- Trial name
- NCT01813812
- Testing
- DA-6034, Rebamipide 300mg
- Where
- South Korea
- Volunteers
- 492 people
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
Gastritis Acute, Gastritis Chronic
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
- Trial name
- NCT06151210
- Testing
- DA-5219, Stillen® Tab
- Where
- South Korea
- Volunteers
- 467 people
- Sponsor
- Dong-A ST Co., Ltd.
Acute and Chronic Gastric Inflammation Patients
Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
The purpose of this study is to find optimum dosage of DW-3101 by evaluating efficacy and safety of each dosage group in Korean patients with acute and chronic gastric inflammation.
- Trial name
- NCT02386007
- Testing
- DW-3101_150mg, DW-3101_300mg, DW-3101_600mg
- Volunteers
- 60 people
- Sponsor
- Daewon Pharmaceutical Co., Ltd.
Non Erosive Reflux Disease, Chronic Gastritis
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
To compare the symptom control rate between 8 weeks esomeprazole treatment regimen group and 2 weeks esomeprazole treatment regimen group in co-diagnosed NERD and chronic gastritis patients, as evaluated by GerdQ after 24 weeks…
- Trial name
- NCT01119768
- Testing
- Esomeprazole
- Where
- 8 sites in China
- Volunteers
- 305 people
- Sponsor
- AstraZeneca
Acute Gastritis, Chronic Gastritis
A Study to Evaluate the Efficacy and Safety of AD-203
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab.
- Trial name
- NCT04066530
- Testing
- AD-203, Mucosta tab.
- Where
- South Korea
- Volunteers
- 475 people
- Sponsor
- Addpharma Inc.